Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review
- PMID: 32762743
- PMCID: PMC7409632
- DOI: 10.1186/s13756-020-00786-7
Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review
Abstract
Background: The emergence and spread of antimicrobial resistance (AMR) present a challenge to disease control in East Africa. Resistance to beta-lactams, which are by far the most used antibiotics worldwide and include the penicillins, cephalosporins, monobactams and carbapenems, is reducing options for effective control of both Gram-positive and Gram-negative bacteria. The World Health Organization, Food and Agricultural Organization and the World Organization for Animal Health have all advocated surveillance of AMR using an integrated One Health approach. Regional consortia also have strengthened collaboration to address the AMR problem through surveillance, training and research in a holistic and multisectoral approach. This review paper contains collective information on risk factors for transmission, clinical relevance and diversity of resistance genes relating to extended-spectrum beta-lactamase-producing (ESBL) and carbapenemase-producing Enterobacteriaceae, and Methicillin-resistant Staphylococcus aureus (MRSA) across the human, animal and environmental compartments in East Africa.
Main body: The review of the AMR literature (years 2001 to 2019) was performed using search engines such as PubMed, Scopus, Science Direct, Google and Web of Science. The search terms included 'antimicrobial resistance and human-animal-environment', 'antimicrobial resistance, risk factors, genetic diversity, and human-animal-environment' combined with respective countries of East Africa. In general, the risk factors identified were associated with the transmission of AMR. The marked genetic diversity due to multiple sequence types among drug-resistant bacteria and their replicon plasmid types sourced from the animal, human and environment were reported. The main ESBL, MRSA and carbapenem related genes/plasmids were the blaCTX-Ms (45.7%), SCCmec type III (27.3%) and IMP types (23.8%), respectively.
Conclusion: The high diversity of the AMR genes suggests there may be multiple sources of resistance bacteria, or the possible exchange of strains or a flow of genes amongst different strains due to transfer by mobile genetic elements. Therefore, there should be harmonized One Health guidelines for the use of antibiotics, as well as regulations governing their importation and sale. Moreover, the trend of ESBLs, MRSA and carbapenem resistant (CAR) carriage rates is dynamic and are on rise over time period, posing a public health concern in East Africa. Collaborative surveillance of AMR in partnership with regional and external institutions using an integrated One Health approach is required for expert knowledge and technology transfer to facilitate information sharing for informed decision-making.
Keywords: Antimicrobial resistance; East Africa; Genetic diversity; Human-animal-environment; Risk factors.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Carbapenemase and ESBL genes with class 1 integron among fermenting and nonfermenting bacteria isolated from water sources from India.Lett Appl Microbiol. 2020 Jul;71(1):70-77. doi: 10.1111/lam.13228. Epub 2019 Nov 8. Lett Appl Microbiol. 2020. PMID: 31587338
-
Presence & mobility of antimicrobial resistance in Gram-negative bacteria from environmental samples in coastal Karnataka, India.Indian J Med Res. 2019 Feb;149(2):290-294. doi: 10.4103/ijmr.IJMR_2088_17. Indian J Med Res. 2019. PMID: 31219097 Free PMC article.
-
HIV Drugs Inhibit Transfer of Plasmids Carrying Extended-Spectrum β-Lactamase and Carbapenemase Genes.mBio. 2020 Feb 25;11(1):e03355-19. doi: 10.1128/mBio.03355-19. mBio. 2020. PMID: 32098822 Free PMC article.
-
The crisis of carbapenemase-mediated carbapenem resistance across the human-animal-environmental interface in India.Infect Dis Now. 2023 Feb;53(1):104628. doi: 10.1016/j.idnow.2022.09.023. Epub 2022 Oct 12. Infect Dis Now. 2023. PMID: 36241158 Review.
-
Systematic review and meta-analysis on antimicrobial resistance and drug resistance in Saudi Arabia.J Glob Antimicrob Resist. 2024 Dec;39:128-136. doi: 10.1016/j.jgar.2024.07.013. Epub 2024 Aug 27. J Glob Antimicrob Resist. 2024. PMID: 39197653
Cited by
-
Genetic characterization of Staphylococcus aureus isolated from Norway rats in Boston, Massachusetts.Vet Med Sci. 2023 Jan;9(1):272-281. doi: 10.1002/vms3.1020. Epub 2022 Dec 16. Vet Med Sci. 2023. PMID: 36524786 Free PMC article.
-
Comparative analysis of clinical breakpoints, normalized resistance interpretation and epidemiological cut-offs in interpreting antimicrobial resistance of Escherichia coli isolates originating from poultry in different farm types in Tanzania.Access Microbiol. 2023 Jul 14;5(7):acmi000540.v4. doi: 10.1099/acmi.0.000540.v4. eCollection 2023. Access Microbiol. 2023. PMID: 37601443 Free PMC article.
-
Quantifying the Relationship between Antibiotic Use in Food-Producing Animals and Antibiotic Resistance in Humans.Antibiotics (Basel). 2022 Jan 6;11(1):66. doi: 10.3390/antibiotics11010066. Antibiotics (Basel). 2022. PMID: 35052943 Free PMC article.
-
Assessing Environmental Factors within the One Health Approach.Medicina (Kaunas). 2021 Mar 5;57(3):240. doi: 10.3390/medicina57030240. Medicina (Kaunas). 2021. PMID: 33807528 Free PMC article. Review.
-
Genomic Characterization of Extended-Spectrum β-Lactamase-Producing and Third-Generation Cephalosporin-Resistant Escherichia coli Isolated from Stools of Primary Healthcare Patients in Ethiopia.Antibiotics (Basel). 2024 Sep 5;13(9):851. doi: 10.3390/antibiotics13090851. Antibiotics (Basel). 2024. PMID: 39335024 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- MR/M01360X/1/MRC_/Medical Research Council/United Kingdom
- MR/N010469/1/MRC_/Medical Research Council/United Kingdom
- MR/R025576/1/MRC_/Medical Research Council/United Kingdom
- MR/R020973/1/MRC_/Medical Research Council/United Kingdom
- BB/R013063/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical